APA (7th ed.) Citation

Rao, M., Chen, D., Zhan, P., & Jiang, J. (2019). MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway. BMC.

Chicago Style (17th ed.) Citation

Rao, Mei, Dongfeng Chen, Peng Zhan, and Jianqing Jiang. MDA19, a Novel CB2 Agonist, Inhibits Hepatocellular Carcinoma Partly Through Inactivation of AKT Signaling Pathway. BMC, 2019.

MLA (9th ed.) Citation

Rao, Mei, et al. MDA19, a Novel CB2 Agonist, Inhibits Hepatocellular Carcinoma Partly Through Inactivation of AKT Signaling Pathway. BMC, 2019.